JUBLINGREA logo

Jubilant Ingrevia Limited Stock Price

NSEI:JUBLINGREA Community·₹105.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

JUBLINGREA Share Price Performance

₹667.40
-127.00 (-15.99%)
46.6% undervalued intrinsic discount
₹1,250.00
Fair Value
₹667.40
-127.00 (-15.99%)
46.6% undervalued intrinsic discount
₹1,250.00
Fair Value
Price ₹667.40
AnalystHighTarget ₹1,250.00
AnalystConsensusTarget ₹967.67
AnalystLowTarget ₹743.00

JUBLINGREA Community Narratives

AnalystHighTarget·Updated
Fair Value ₹1.25k 46.6% undervalued intrinsic discount

Rising Green Chemistry Demand Will Reimagine Global Specialty Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value ₹944.75 29.4% undervalued intrinsic discount

EU Antidumping Duties And China+1 Diversification Will Unlock Export Opportunities

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystLowTarget·Updated
Fair Value ₹743 10.2% undervalued intrinsic discount

Regulatory Tensions And China+1 Shifts Will Test Recovery Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent JUBLINGREA News & Updates

The Price Is Right For Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Sep 20
The Price Is Right For Jubilant Ingrevia Limited (NSE:JUBLINGREA)

We Like These Underlying Return On Capital Trends At Jubilant Ingrevia (NSE:JUBLINGREA)

Jul 03
We Like These Underlying Return On Capital Trends At Jubilant Ingrevia (NSE:JUBLINGREA)

Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results

May 16
Jubilant Ingrevia Limited (NSE:JUBLINGREA) Analysts Are Pretty Bullish On The Stock After Recent Results

Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Share Price Matching Investor Opinion

Apr 22
Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Share Price Matching Investor Opinion

Jubilant Ingrevia Limited Key Details

₹41.9b

Revenue

₹25.4b

Cost of Revenue

₹16.5b

Gross Profit

₹13.7b

Other Expenses

₹2.8b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
17.55
Gross Margin
39.31%
Net Profit Margin
6.62%
Debt/Equity Ratio
26.1%

Jubilant Ingrevia Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
3 Rewards

About JUBLINGREA

Founded
2019
Employees
2139
CEO
Deepak Jain
WebsiteView website
jubilantingrevia.com

Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: -0.6%
  • 3 Months: -2.2%
  • 1 Year: -6.0%
  • Year to Date: 0.2%
The market has stayed flat over the 7 days. Unfortunately though, the market is down 6.0% over the past year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›